NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









HypnoVR

HypnoVR

Private
StrasbourgHealthcare & Life Scienceshttps://hypnovr.io/fr/

Last Round

Series A

Dec 7, 2021

Total Funding Raised

$5.93M

Company Overview

HypnoVR is a healthcare technology company that develops a virtual reality-based medical device designed to manage pain, stress, and anxiety.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, AR/VR Experiences, Mental Health

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Non-AI

Keywords

digital therapeuticsvirtual reality therapyDTxmedical VRpain managementanxiety managementVR hypnosisnon-pharmacological sedationsedation alternativemedical devicetherapeutic VRmedical hypnosisopioid reductionCE-marked medical devicedental VRsurgical VRcorporate wellness

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HypnoVR Comparables

Compare HypnoVR with similar companies based on industry and business-model similarity.

HypnoVR comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VRelax
84%
SyncVR Medical
82%
Firsthand Technology Inc.
78%

HypnoVR Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 7, 2021
SeedJun 13, 2018

Key People

Founding team and executive leadership

Nicolas Schaettel

Cofounder & CEO - Medical Hypnosis Trough Virtual Reality Software To Treat Pain And Anxiety

Founding Team

Michael Paquereau

Chief Technology Officer

Executive Team

HypnoVR Investors

Notable investors and investment history

HypnoVR investors
InvestorRounds
Banque des TerritoiresSeries A
Capital Grand EstSeries A
TheodorusSeries A
AkilesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 7, 2023

    Grew 18% QoQ, from 28 to 33 employees.

  • Nov 25, 2023

    Grew 19% QoQ, from 27 to 32 employees.

HypnoVR Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

HypnoVR Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about HypnoVR's valuation, stock price, and market status.

Firmographic Details

HeadquartersStrasbourg
Employee Range21
Year Founded2016
Last FundingDec 7, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.